Lawrence R M, Huang P T, Glick J, Oppenheim J D, Maas W K
Department of Microbiology, New York University School of Medicine, New York 10016.
Infect Immun. 1990 Apr;58(4):970-7. doi: 10.1128/iai.58.4.970-977.1990.
This study involved the construction of hybrid plasmids to produce heat-stable enterotoxin type II of Escherichia coli (STb). The translation of the open reading frame for the STb gene estA was demonstrated in several ways. Studies using in vivo labeling with [35S]cysteine demonstrated a radiolabeled protein band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the expected molecular weight of 5,000 for toxin STb. Insertion of translational or transcriptional termination signals into the BglII site of the estA gene blocked the expression of estA. The estA gene was cloned into high-expression vector pKC30 downstream from the strong pL promoter. Northern (RNA) blotting assays revealed a 10- to 20-fold increase in mRNA produced by strain C600F(pKC30STb) over other STb-producing strains, compared with little or no increase in enterotoxin activity demonstrated by bioassay. The estA gene, with its own promoter and Shine-Delgarno region and a portion of the sequence for the signal peptide deleted, was also inserted under the control of the tac promoter. Even after induction of the tac promoter by addition of isopropyl-beta-D-thiogalactopyranoside, no biologic enterotoxin activity could be identified. Neutralizing antibodies to STb were produced in rabbits by using either a purified OmpF-STb-beta-galactosidase fusion protein or a 19-amino-acid synthetic STb peptide coupled to keyhole limpet hemocyanin.
本研究涉及构建杂交质粒以产生大肠杆菌II型热稳定肠毒素(STb)。通过多种方式证明了STb基因estA开放阅读框的翻译。使用[35S]半胱氨酸进行体内标记的研究表明,在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上出现了一条放射性标记的蛋白带,其分子量与毒素STb预期的5000一致。将翻译或转录终止信号插入estA基因的BglII位点会阻断estA的表达。estA基因被克隆到强pL启动子下游的高表达载体pKC30中。Northern(RNA)印迹分析显示,与生物测定法显示的肠毒素活性几乎没有增加或没有增加相比,菌株C600F(pKC30STb)产生的mRNA比其他产生STb的菌株增加了10至20倍。estA基因,带有其自身的启动子和Shine-Delgarno区域,且信号肽序列的一部分被删除,也被插入到tac启动子的控制下。即使通过添加异丙基-β-D-硫代半乳糖苷诱导tac启动子,也未检测到生物肠毒素活性。通过使用纯化的OmpF-STb-β-半乳糖苷酶融合蛋白或与匙孔血蓝蛋白偶联的19个氨基酸的合成STb肽,在兔体内产生了针对STb的中和抗体。